United States v. California Stem Cell Treatment Center, Inc.
Opinion
Trial Court Opinion
Case 5:18-cv-01005-JGB-KK Document 190 Filed 08/30/ Page 1 of Page ID #:4641
1 2 3 4
UNITED STATES DISTRICT COURT
CENTRAL DISTRICT OF CALIFORNIA – EASTERN DIVISION
8 UNITED STATES OF AMERICA, Case No. 9 EDCV 18-1005 JGB (KKx) Plaintiff, v.
FINDINGS OF FACT AND
CALIFORNIA STEM CELL TREATMENT CONCLUSIONS OF LAW CENTER, INC., et al. 13 Defendants.
15 16 17
20 21 22
25 26 27 28 Case 5:18-cv-01005-JGB-KK Document 190 Filed 08/30/ Page 2 of Page ID #:4642
This is a statutory injunction proceeding in which the United States, on behalf of the U.S. Food and Drug Administration (“FDA”), seeks to permanently enjoin Defendants California Stem Cell Treatment Center, Inc., Cell Surgical Network Corporation, and Drs. Elliot B. Lander, M.D., and Mark Berman, M.D., from performing various stem cell treatments on patients. The United States alleges these treatments violate the Federal Food, Drug, and Cosmetic Act (“FDCA”). Specifically, the United States alleges that three of Defendants’ stromal vascular stem cell…